John C. McKew
Chief Scientific Officer · LUMOS PHARMA, INC.
Individual
- 2024
- Dec 13, 2024
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at John C. McKew's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
- Andrew T. Kaplan - $134.38M in KLRA purchases and sales in the last 12 months
- BAIN CAPITAL INVESTORS LLC - $134.38M in KLRA purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $133.53M in APGE purchases and sales in the last 12 months
- Stephen M. Bloch - $125.05M in LQDA purchases and sales in the last 12 months
- Jason P. Rhodes - $124.92M in DYN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John C. McKew?
John C. McKew is a corporate insider, tracked as Chief Scientific Officer of LUMOS PHARMA, INC. (LUMO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did John C. McKew last file a Form 4?
The only primary Form 4 on record is dated 13 December 2024.
